Jason Bablak is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as Vice President of Regulatory Affairs at Taysha Gene Therapies since September 2025. Bablak has significant experience in regulatory science and operations, having held leadership roles at companies like Orchard Therapeutics, Attune Pharmaceuticals, THAR Pharmaceuticals, and LEV Pharmaceuticals. Bablak's background includes overseeing regulatory strategy and activities in clinical-stage biotechnology companies focused on gene therapy and orphan diseases, as well as managing overall operations, investor relations, and successful product development initiatives. Bablak holds a Doctor of Law degree from the University of Pittsburgh School of Law and a Bachelor of Science degree in Biology and Environmental Science from Allegheny College.
This person is not in any teams
This person is not in any offices